tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Immutep reports Q2 cash receipts from customers A$4,000
The FlyImmutep reports Q2 cash receipts from customers A$4,000
2d ago
IMMP
Immutep Secures Dr. Reddy’s Partnership and Strengthens Clinical, Financial Position
PremiumCompany Announcements
Immutep Secures Dr. Reddy’s Partnership and Strengthens Clinical, Financial Position
3d ago
Immutep announces update on IMP761 from Phase I study
PremiumThe Fly
Immutep announces update on IMP761 from Phase I study
1M ago
IMMP
Immutep Reports Promising Phase I Data for First-in-Class Autoimmune Antibody IMP761
PremiumCompany Announcements
Immutep Reports Promising Phase I Data for First-in-Class Autoimmune Antibody IMP761
1M ago
Immutep announces progress in global TACTI-004 Phase III, enrollment continues
PremiumThe Fly
Immutep announces progress in global TACTI-004 Phase III, enrollment continues
2M ago
MRK
IMMP
Immutep Advances Global Phase III Trial for Lung Cancer Therapy
PremiumCompany AnnouncementsImmutep Advances Global Phase III Trial for Lung Cancer Therapy
2M ago
Immutep’s Strategic Partnership with Dr. Reddy’s Fuels Growth Potential and Strengthens Financial Position
Premium
Ratings
Immutep’s Strategic Partnership with Dr. Reddy’s Fuels Growth Potential and Strengthens Financial Position
2M ago
IMMP
Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
Premium
The Fly
Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
2M ago
V
GM
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
PremiumThe Fly
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
2M ago
RDY
IMMP
Immutep and Dr. Reddy’s Forge Strategic Partnership for Global Oncology Drug Commercialization
PremiumCompany Announcements
Immutep and Dr. Reddy’s Forge Strategic Partnership for Global Oncology Drug Commercialization
2M ago
Immutep Ltd Announces Director’s Interest Change
PremiumCompany Announcements
Immutep Ltd Announces Director’s Interest Change
2M ago
Immutep Ltd Director Acquires Performance Rights as Remuneration
PremiumCompany Announcements
Immutep Ltd Director Acquires Performance Rights as Remuneration
2M ago
Immutep Director’s Interest Update Reflects Strategic Alignment
PremiumCompany AnnouncementsImmutep Director’s Interest Update Reflects Strategic Alignment
2M ago
Immutep Limited Announces New Securities Quotation on ASX
Premium
Company Announcements
Immutep Limited Announces New Securities Quotation on ASX
2M ago
Immutep to present data from AIPAC-003 Phase II trial
Premium
The Fly
Immutep to present data from AIPAC-003 Phase II trial
2M ago
IMMP
Immutep Limited Issues New Performance Rights to Employees
PremiumCompany Announcements
Immutep Limited Issues New Performance Rights to Employees
2M ago
Immutep’s Eftilagimod Alfa Shows Promising Results in Breast Cancer Trial
PremiumCompany Announcements
Immutep’s Eftilagimod Alfa Shows Promising Results in Breast Cancer Trial
2M ago
Immutep Ltd Updates Business Strategy at AGM 2025
PremiumCompany Announcements
Immutep Ltd Updates Business Strategy at AGM 2025
2M ago
Immutep announces data from EFTISARC-NEO trial
PremiumThe Fly
Immutep announces data from EFTISARC-NEO trial
3M ago
IMMP
Immutep’s EFTISARC-NEO Trial Shows Promising Results in Soft Tissue Sarcoma
PremiumCompany AnnouncementsImmutep’s EFTISARC-NEO Trial Shows Promising Results in Soft Tissue Sarcoma
3M ago
Immutep receives EUR 2,588,954 R&D tax incentive from French Government
Premium
The Fly
Immutep receives EUR 2,588,954 R&D tax incentive from French Government
3M ago
IMMP
Immutep Secures A$4.6 Million R&D Tax Incentive from French Government
Premium
Company Announcements
Immutep Secures A$4.6 Million R&D Tax Incentive from French Government
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >